Benzenesulfonamide compounds and their use as therapeutic agents
US-9630929-B2 · Apr 25, 2017 · US
Therapeutic compounds and methods of use thereof
US11028075B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11028075-B2 |
| Application number | US-201916283451-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 22, 2019 |
| Priority date | Feb 26, 2018 |
| Publication date | Jun 8, 2021 |
| Grant date | Jun 8, 2021 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The invention provides benzene sulfonamides and pharmaceutically acceptable salt thereof that are useful as sodium channel blockers for the treatment of, for example, pain. The following compound is illustrative:
First claim
Opening claim text (preview).
We claim: 1. A compound selected from the group consisting of: or a pharmaceutically acceptable salt thereof. 2. A pharmaceutical composition comprising a compound of claim 1 , or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable excipient. 3. The compound of claim 1 , which is: or a pharmaceutically acceptable salt thereof. 4. The compound of claim 1 , which is: or a pharmaceutically acceptable salt thereof. 5. The compound of claim 1 , which is: or a pharmaceutically acceptable salt thereof. 6. The compound of claim 1 , which is: or a pharmaceutically acceptable salt thereof. 7. The compound of claim 1 , which is: or a pharmaceutically acceptable salt thereof. 8. The compound of claim 1 , which is: or a pharmaceutically acceptable salt thereof. 9. The compound of claim 1 , which is: or a pharmaceutically acceptable salt thereof. 10. The compound of claim 1 , which is: or a pharmaceutically acceptable salt thereof.
Assignees
Inventors
Classifications
not condensed and containing further heterocyclic rings · CPC title
- C07D413/12Primary
linked by a chain containing hetero atoms as chain links · CPC title
ortho- or peri-condensed with carbocyclic ring systems · CPC title
Heterocyclic compounds · CPC title
Benzenesulfonamido-pyrimidines · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US11028075B2 cover?
- The invention provides benzene sulfonamides and pharmaceutically acceptable salt thereof that are useful as sodium channel blockers for the treatment of, for example, pain. The following compound is illustrative:
- Who is the assignee on this patent?
- Genentech Inc
- What technology area does this patent fall under?
- Primary CPC classification C07D413/12. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Jun 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).